SCHEDULE: Vivo Opportunity Funds Adjust Entera Bio Stake

Several Vivo Opportunity entities have updated their beneficial ownership filings for Entera Bio Ltd., reflecting significant holdings and voting power.

Summary

• This filing is a Schedule 13G, indicating a change in beneficial ownership of Entera Bio Ltd. ordinary shares by various Vivo Opportunity entities.
• Vivo Opportunity, LLC, as the general partner for several funds, holds significant beneficial ownership.
• The total number of ordinary shares outstanding is stated as 172,251,411, following a private placement on July 28, 2026.
• The filing details the sole voting and dispositive power for each reporting entity.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, primarily indicating a change in beneficial ownership rather than new operational or financial performance data.

Positives

• The filing clearly outlines the beneficial ownership of several Vivo Opportunity entities in Entera Bio Ltd.
• The aggregate beneficial ownership by Vivo Opportunity, LLC is 11,817,401 shares, representing 6.9% of the class.
• The filing confirms the total number of outstanding shares after a recent private placement, providing updated context.

Negatives

• The filing does not contain any financial performance data, operational updates, or forward-looking guidance.
• It is a disclosure of ownership, not an indicator of company performance or strategic direction.

Risks

• The primary risk is that the significant stake held by Vivo Opportunity could lead to future influence or changes in corporate strategy, the nature of which is not detailed.
• Concentration of ownership by a single group could potentially impact liquidity or market perception if their strategy shifts.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Entera Bio Ltd.'s future performance.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and investment funds that acquire a significant stake in a company. This filing indicates a substantial investment by Vivo Opportunity entities in Entera Bio Ltd., which could signal confidence or a strategic interest in the company's sector, though the specific reasons are not disclosed.

Stakeholder Impact

• Shareholders: The significant stake held by Vivo Opportunity may influence future corporate decisions, potentially impacting share price and long-term value.
• Management: The increased ownership by an investment group may lead to increased scrutiny or engagement with the company's management.
• Creditors: Changes in corporate strategy driven by major shareholders could indirectly affect the company's financial stability and ability to meet obligations.

Next Steps

• Monitor future filings from Vivo Opportunity entities for any changes in beneficial ownership or strategic actions.
• Observe Entera Bio Ltd.'s operational and financial performance to understand the context of this significant ownership stake.

Key Dates

Keywords

Entera Bio Ltd., Schedule 13G, Beneficial Ownership, Vivo Opportunity, Ordinary Shares, Private Placement, Voting Power, Investment Funds